Novax Pharma SAM

Since its creation, NOVAX®PHARMA has been working in partnership with scientists and doctors from different research centres such as Italy (Rome), and in France (Sophia-Antipolis). Research and innovation is our driving force.

From the manufacturer's own website. Source

Novax Pharma SAM manufactures topical ophthalmic solutions, including daily and intensive care formulations for eye hygiene and irritation relief, such as NAVIBLEF DAILY CARE and NAVIBLEF INTENSIVE CARE. Their portfolio also includes lubricating sprays for dry and red eyes, like FLORA VISION SPRAY variants, as well as preservative-free eye drops like NAVITAE PLUS PF and NAVI®LIPO. Additional products address specific concerns, such as NAVIVISION PLUS for tired eyes and NAVI INFLA for inflammation management.

The company’s devices are classified under EU Medical Device Regulations as Class I, Class IIa, and Class IIb, with all products registered in the EU’s eudamed database. The manufacturer is based in Monaco and adheres to regulatory requirements for ophthalmic and topical medicinal products within the European Union.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.